Clinical Trial Update: A Study of DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy Infants [Phase 3]

View source ↗

Summary

This Phase 3 trial compares ACTACEL (DTaP-PRP-T) with separate DTaP and Act-HIB vaccines in healthy infants and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type
• Pertussis
• Tetanus

Drugs mentioned

• ACTACEL (DTaP-PRP-T combined vaccine)
• ACTHIB (Haemophilus influenzae type b conjugate vaccine)
• DTaP (Diphtheria, Tetanus, and Acellular Pertussis vaccine)

Snippet

Sponsor: Sanofi | Conditions: Diphtheria, Tetanus | Phase 3 | Status: COMPLETED